Toxic shock syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}};{{AE}}{{MIR}} | |||
{{Toxic shock syndrome}} | {{Toxic shock syndrome}} | ||
== Overview: == | |||
[[Secondary prevention]] strategies following [[toxic shock syndrome]] (TSS) include [[chemoprophylaxis]] for invasive group A [[streptococcus]] or [[staphylococcus]] carriers. Although it is still not certain to be helpful. | |||
== Secondary Prevention == | |||
One of the major complications of [[toxic shock syndrome]] is that it increase the risk of disease re-currence. This condition can be controlled by [[chemoprophylaxis]] of patients with a past medical history of [[Toxic shock syndrome|TSS]]. However, there is limited data concerning [[chemoprophylaxis]] for severe invasive group A [[Streptococcus|streptococcal]] or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref> | |||
*Also researchers advice not to continue tampon usage after a TSS, to prevent the recurrence of the disease. | |||
*Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers i.e., | |||
**[[Rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or | |||
**A 10-day course of a second-generation [[cephalosporin]] or | |||
**[[Clindamycin]]) | |||
==References== | ==References== | ||
| Line 20: | Line 20: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[Category:Needs content]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 00:27, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
|
Toxic shock syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic shock syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Toxic shock syndrome secondary prevention |
|
Risk calculators and risk factors for Toxic shock syndrome secondary prevention |
Overview:
Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.
Secondary Prevention
One of the major complications of toxic shock syndrome is that it increase the risk of disease re-currence. This condition can be controlled by chemoprophylaxis of patients with a past medical history of TSS. However, there is limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.[1][2]
- Also researchers advice not to continue tampon usage after a TSS, to prevent the recurrence of the disease.
- Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers i.e.,
- Rifampin plus intramuscular benzathine penicillin or
- A 10-day course of a second-generation cephalosporin or
- Clindamycin)
References
- ↑ "Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics".
- ↑ Wylie A (1918). "Epithelioma of Soft Palate and Uvula". Proc. R. Soc. Med. 11 (Laryngol Sect): 110–1. PMC 2066844. PMID 19980033.